Improvement of blood glucose control in type 1 diabetic patients treated with lispro and multiple NPH injections

Diabetic Medicine

Volumn 16, Issue 4, 1999, Pages 319-324

  Colombel, A ^a   Murat, A ^a   Krempf, M ^a   Kuchly Anton, B ^a   Charbonnel, Bernard ^a,b  

^a Clinique d'Endocrinologie Hotel Dieu CHU de Nantes   (France)

^b HÔTEL DIEU   (France)

Author keywords

Blood glucose variability; Insulin analogues; Intensive insulin therapy; Lispro; Multiple daily injections

Indexed keywords

C PEPTIDE; GLUCOSE; HEMOGLOBIN A1C; HUMAN INSULIN; INSULIN LISPRO; ISOPHANE INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; BLOOD GLUCOSE; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN, ISOPHANE; PATIENT SATISFACTION; SOLUBILITY; TREATMENT OUTCOME;

EID: 0032758545     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.1999.00077.x     Document Type: Article

References (19)

1. 1 Holleman F, Hoekstra BL. Insulin lispro. N Engl J Med 1997; 337: 176-183.
2. 2 Garg SK, Carmain JA, Braddy KC, Anderson JH, Vignatì L, Jennings MK et al. Pre-meal insulin analogue insulin lispro vs Humulin R insulin treatment in young subjects with type 1 diabetes. Diabetic Med 1996; 13: 47-52.
3. 3 Anderson JH, Brunelle RL, Koivisto VA, Pfützner A, Trautmann ME, Vignati L et al. Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Diabetes 1997; 46: 265-270.
4. 4 Pampanelli S, Torlone E, Lalli C, Del Sindaco P, Ciofetta M, Lepore M et al. Improved post-prandial metabolic control after subcutaneous injection of a short-acting insulin analogue in IDDM of short duration with residual pancreatic B-cell function. Diabetes Care 1995; 18: 1452-1459.
5. 5 Torlone E, Pampanelli S, Lalli C, Del Sindaco P, Di Vincenzo A, Rambotti AM et al. Effects of the short-acting insulin analog [Lys (B28), Pro (B29)] on postprandial blood glucose control in IDDM. Diabetes Care 1996; 19: 945-952.
6. 6 Zinman B, Tildesley H, Chiasson J-L, Tsui E, Strack T. Insulin lispro in CSII. Results of a double-blind crossover study. Diabetologia 1997; 46: 440-443.
7. 7 Melki V, Renard E, Lassmann-Vague V, Boivin S, Guerci B, Hanaire-Broutin H et al. Improvement of HbA1c and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps. Diabetes Care 1998; 21: 977-982.
8. 8 Antsiferov M, Woodworth JR, Mayorov A, Ristic S, Devov I. Within patient variability in postprandial glucose excursion with lispro insulin analog compared with soluble insulin. Diabetologia 1995; 38: A190.
9. 9 Del Sindaco P, Coifetta M, Lalli C, Perriello G, Pampanelli S, Torlone E et al. Use of the short-acting insulin analogue lispro in intensive treatment of Type 1 diabetes mellitus: importance of appropriate replacement of basal insulin and time-interval injection-meal. Diabet Med 1998; 15: 592-600.
10. 10 Molnar GD, Taylor WF, Ho MM. Day-to-day variation of continuously monitored glycemia: a further measure of diabetic instability. Diabetologia 1972; 8: 342-348.
11. 11 Service FJ, Molnar GD, Roswear JW, Ackerman E, Gatewood LC, Taylor WF et al. Mean amplitude of glycemia excursions, a measure of diabetic instability. Diabetes 1970; 19: 644-655.
12. 12 Service FJ, Nelson RL. Characteristics of glycemic stability. Diabetes Care 1980; 1: 1980.
13. 13 Service FJ, Molnar GD. Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 1970; 19: 644-655.
14. 14 Service FJ, O'Brien PC. Measurements of glucose control. Diabetes Care 1987; 10: 225-237.
15. 15 Koch GG. The use of non-parametric methods in the statistical analysis of the two-period change-over design. Biometrics 1972; 28: 1972.
16. 16 Taulbee JD. A note on the use of nonparametric methods in the statistical analysis of the two-period change-over design. Biometrics 1982; 38: 1053-1055.
17. 17 Woodworth JR, Howey DC, Bowsher RR. Establishment of time-action profiles for soluble and NPH insulin using pharmacodynamic modeling. Diabetes Care 1994; 17: 64-69.
18. 18 Ebeling P, Jansson P-R, Smith U, Lalli C, Bolli GB, Koivisto V. Strategies toward improved control during insulin lispro therapy in IDDM. Diabetes Care 1997; 20: 1287-1289.
19. 19 Schmitt H, Symanowski SM, Holleman R, Rees A, Rottiers R, Anderson JH. Comparison of pre-meal therapy with insulin lispro and soluble insulin in patients with IDDM. Diabetologia 1996; 39: A221.